MedTrace Logo

Resistant Starch Blend Gastrointestinal Impact

NCT03983772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-04-06

No results posted yet for this study

Summary

This study aims to test the hypothesis that a unique blend of resistant starches and fiber will promote gastrointestinal health, as measured by an increase in short-chain fatty acids and improvement in quality of life measures in conjunction with microbial community changes. This study specifically evaluates the impact on short-chain fatty acids and gut microbiota and the impact on quality of life from a resistant starch blend in healthy adult humans with occasional gastrointestinal distress.

Conditions

  • Quality of Life
  • Health, Subjective

Interventions

DIETARY_SUPPLEMENT

RS blend

The intervention is a proprietary resistant starch blend.

OTHER

Placebo

The placebo is starch.

Sponsors & Collaborators

  • Personalized Lifestyle Medicine Center

    collaborator UNKNOWN

  • National University of Natural Medicine

    collaborator OTHER

  • Metagenics, Inc.

    lead INDUSTRY

Principal Investigators

  • Noelle Patno, PhD · Metagenics, Inc.

  • Joseph Lamb, MD · PLMC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-14
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03983772 on ClinicalTrials.gov